Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells

Luke M. Koong, Cheryl S. Watson

Research output: Contribution to journalArticle

24 Downloads (Pure)

Abstract

Xenoestrogens (XEs) are exogenous mimics capable of binding to estrogen receptors (ERs), competing with disrupting the actions of physiological estrogens, and promoting tumor growth in the prostate and other endocrine
tissues. Humans are exposed to numerous XEs including environmental contaminants such as plastics monomer bisphenol A (BPA), and dietary phytoestrogens such as coumestrol and genistein from soy, and resveratrol, highest in red grapes. There is growing interest in the ability of phytoestrogens to prevent or treat tumors. We previously reported that multiple cellular mechanisms influence the number of prostate cancer cells after estradiol or diethylstilbestrol treatment. We now examine the effect of these XEs on signaling mechanisms that alter the number of LAPC-4 (androgen-dependent) and PC-3 (androgen-independent) cells at environment- and diet-relevant concentrations.
Coumestrol and genistein both increased the number of LAPC-4 and PC-3 cells dramatically. Rapid alterations of phospho- and total-cyclin D1 levels most closely correlated with the XE-induced changes in cell numbers. Sustained
activation (phosphorylation) of the extracellular signal-regulated kinases 1 and 2 as a prelude to generation of reactive oxygen species also partially contributed to the XE’s effects on cell numbers. Early-stage cells expressed higher levels of
all 3 ERs (including those in membranes) than did late-stage cells; ER subtypes were variably involved in the signaling responses. Taken together, these results show that each XE can elicit its own signature constellation of signaling responses, highlighting the importance of managing exposures to both environmental and dietary XEs for existing prostate tumors. These mechanisms may offer new cellular targets for therapy.
Original languageEnglish (US)
JournalEndocrine Disruptors
Volume3
Issue number1
StatePublished - 2015

Fingerprint

Prostatic Neoplasms
Cell Survival
Coumestrol
Estrogen Receptors
Phytoestrogens
Genistein
Androgens
Prostate
Cell Count
Neoplasms
Diethylstilbestrol
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Cyclin D1
Vitis
Plastics
Estradiol
Reactive Oxygen Species
Estrogens
Phosphorylation

Keywords

  • BPA
  • resveratrol
  • coumestrol
  • diet
  • genistein
  • membrane estrogen receptor

Cite this

Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells. / Koong, Luke M.; Watson, Cheryl S.

In: Endocrine Disruptors, Vol. 3, No. 1, 2015.

Research output: Contribution to journalArticle

@article{09e1c2e9fdca4f90a3659b41fd2fff5f,
title = "Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells",
abstract = "Xenoestrogens (XEs) are exogenous mimics capable of binding to estrogen receptors (ERs), competing with disrupting the actions of physiological estrogens, and promoting tumor growth in the prostate and other endocrinetissues. Humans are exposed to numerous XEs including environmental contaminants such as plastics monomer bisphenol A (BPA), and dietary phytoestrogens such as coumestrol and genistein from soy, and resveratrol, highest in red grapes. There is growing interest in the ability of phytoestrogens to prevent or treat tumors. We previously reported that multiple cellular mechanisms influence the number of prostate cancer cells after estradiol or diethylstilbestrol treatment. We now examine the effect of these XEs on signaling mechanisms that alter the number of LAPC-4 (androgen-dependent) and PC-3 (androgen-independent) cells at environment- and diet-relevant concentrations.Coumestrol and genistein both increased the number of LAPC-4 and PC-3 cells dramatically. Rapid alterations of phospho- and total-cyclin D1 levels most closely correlated with the XE-induced changes in cell numbers. Sustainedactivation (phosphorylation) of the extracellular signal-regulated kinases 1 and 2 as a prelude to generation of reactive oxygen species also partially contributed to the XE’s effects on cell numbers. Early-stage cells expressed higher levels ofall 3 ERs (including those in membranes) than did late-stage cells; ER subtypes were variably involved in the signaling responses. Taken together, these results show that each XE can elicit its own signature constellation of signaling responses, highlighting the importance of managing exposures to both environmental and dietary XEs for existing prostate tumors. These mechanisms may offer new cellular targets for therapy.",
keywords = "BPA, resveratrol, coumestrol, diet, genistein, membrane estrogen receptor",
author = "Koong, {Luke M.} and Watson, {Cheryl S.}",
year = "2015",
language = "English (US)",
volume = "3",
journal = "Endocrine Disruptors",
publisher = "Taylor and Francis AS",
number = "1",

}

TY - JOUR

T1 - Xenoestrogen-induced signaling leading to cell viability changes on early- vs. late-stage prostate cancer cells

AU - Koong, Luke M.

AU - Watson, Cheryl S.

PY - 2015

Y1 - 2015

N2 - Xenoestrogens (XEs) are exogenous mimics capable of binding to estrogen receptors (ERs), competing with disrupting the actions of physiological estrogens, and promoting tumor growth in the prostate and other endocrinetissues. Humans are exposed to numerous XEs including environmental contaminants such as plastics monomer bisphenol A (BPA), and dietary phytoestrogens such as coumestrol and genistein from soy, and resveratrol, highest in red grapes. There is growing interest in the ability of phytoestrogens to prevent or treat tumors. We previously reported that multiple cellular mechanisms influence the number of prostate cancer cells after estradiol or diethylstilbestrol treatment. We now examine the effect of these XEs on signaling mechanisms that alter the number of LAPC-4 (androgen-dependent) and PC-3 (androgen-independent) cells at environment- and diet-relevant concentrations.Coumestrol and genistein both increased the number of LAPC-4 and PC-3 cells dramatically. Rapid alterations of phospho- and total-cyclin D1 levels most closely correlated with the XE-induced changes in cell numbers. Sustainedactivation (phosphorylation) of the extracellular signal-regulated kinases 1 and 2 as a prelude to generation of reactive oxygen species also partially contributed to the XE’s effects on cell numbers. Early-stage cells expressed higher levels ofall 3 ERs (including those in membranes) than did late-stage cells; ER subtypes were variably involved in the signaling responses. Taken together, these results show that each XE can elicit its own signature constellation of signaling responses, highlighting the importance of managing exposures to both environmental and dietary XEs for existing prostate tumors. These mechanisms may offer new cellular targets for therapy.

AB - Xenoestrogens (XEs) are exogenous mimics capable of binding to estrogen receptors (ERs), competing with disrupting the actions of physiological estrogens, and promoting tumor growth in the prostate and other endocrinetissues. Humans are exposed to numerous XEs including environmental contaminants such as plastics monomer bisphenol A (BPA), and dietary phytoestrogens such as coumestrol and genistein from soy, and resveratrol, highest in red grapes. There is growing interest in the ability of phytoestrogens to prevent or treat tumors. We previously reported that multiple cellular mechanisms influence the number of prostate cancer cells after estradiol or diethylstilbestrol treatment. We now examine the effect of these XEs on signaling mechanisms that alter the number of LAPC-4 (androgen-dependent) and PC-3 (androgen-independent) cells at environment- and diet-relevant concentrations.Coumestrol and genistein both increased the number of LAPC-4 and PC-3 cells dramatically. Rapid alterations of phospho- and total-cyclin D1 levels most closely correlated with the XE-induced changes in cell numbers. Sustainedactivation (phosphorylation) of the extracellular signal-regulated kinases 1 and 2 as a prelude to generation of reactive oxygen species also partially contributed to the XE’s effects on cell numbers. Early-stage cells expressed higher levels ofall 3 ERs (including those in membranes) than did late-stage cells; ER subtypes were variably involved in the signaling responses. Taken together, these results show that each XE can elicit its own signature constellation of signaling responses, highlighting the importance of managing exposures to both environmental and dietary XEs for existing prostate tumors. These mechanisms may offer new cellular targets for therapy.

KW - BPA

KW - resveratrol

KW - coumestrol

KW - diet

KW - genistein

KW - membrane estrogen receptor

M3 - Article

VL - 3

JO - Endocrine Disruptors

JF - Endocrine Disruptors

IS - 1

ER -